1: Agarwal S, Patel T, Shah N, Patel BM. Comparative study of therapeutic response to baclofen vs tolperisone in spasticity. Biomed Pharmacother. 2017 Mar;87:628-635. doi: 10.1016/j.biopha.2017.01.005. Epub 2017 Jan 10. PubMed PMID: 28086137.
2: Martos V, Hofer KE, Rauber-Lüthy C, Schenk-Jaeger KM, Kupferschmidt H, Ceschi A. Acute toxicity profile of tolperisone in overdose: Observational poison centre-based study. Clin Toxicol (Phila). 2015 Jun;53(5):470-6. doi: 10.3109/15563650.2015.1022896. Epub 2015 Mar 14. PubMed PMID: 25772423.
3: Pawlowska M, Bogiel M, Duda J, Sieradzki E. Influence of CYP2D6 and CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy volunteers. Eur J Clin Pharmacol. 2015 Jun;71(6):699-705. doi: 10.1007/s00228-015-1856-5. Epub 2015 May 9. PubMed PMID: 25953735.
4: Kocsis P, Gajári D, Deli L, Gőcze KZ, Pozsgay Z, Tihanyi K. Effect of tolperisone on the resting brain and on evoked responses, an phMRI BOLD study. Brain Res Bull. 2013 Oct;99:34-40. doi: 10.1016/j.brainresbull.2013.09.008. Epub 2013 Oct 4. PubMed PMID: 24099980.
5: Choi CI, Park JI, Lee HI, Lee YJ, Jang CG, Bae JW, Lee SY. Determination of tolperisone in human plasma by liquid chromatography/tandem mass spectrometry for clinical application. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Dec 12;911:59-63. doi: 10.1016/j.jchromb.2012.10.027. Epub 2012 Oct 29. PubMed PMID: 23217307.
6: Owada Y, Takahashi M, Iwasa S, Ichiba H, Sadamoto K, Fukushima T. Enantiomeric separation of tolperisone and eperisone by reversed-phase HPLC with cellulose tris(3-chloro-4-methylphenylcarbamate)-coated chiral column. Biomed Chromatogr. 2014 Jan;28(1):102-5. doi: 10.1002/bmc.2892. Epub 2013 Mar 15. PubMed PMID: 23505060.
7: Sporkert F, Brunel C, Augsburger MP, Mangin P. Fatal tolperisone poisoning: autopsy and toxicology findings in three suicide cases. Forensic Sci Int. 2012 Feb 10;215(1-3):101-4. doi: 10.1016/j.forsciint.2011.05.025. Epub 2011 Jun 17. PubMed PMID: 21683537.
8: Prabhoo R, Keny S, Prabhoo T, Singh A, Rana R. A phase IV observational multi-centre, open-label study on efficacy and safety of tolperisone 150 mg in patients with painful muscle spasm associated with degenerative or inflammatory diseases of the musculoskeletal system. J Assoc Physicians India. 2011 Jan;59:33-7. PubMed PMID: 21751662.
9: Miura N, Saito T, Taira T, Yamagiwa T, Morita S, Inokuchi S. Rapid simultaneous determination of eperisone, tolperisone, and tizanidine in human serum by using a MonoSpin® C18 extraction column and liquid chromatography/tandem mass spectrometry. J AOAC Int. 2014 Nov-Dec;97(6):1546-51. PubMed PMID: 25632432.
10: Nageswara Rao R, Satyanarayana Raju S. Enantioselective separation and simultaneous determination of tolperisone and eperisone in rat plasma by LC-MS/MS. Chirality. 2013 Oct;25(10):622-7. doi: 10.1002/chir.22187. Epub 2013 Jul 9. PubMed PMID: 23840024.
11: Lipták J. [Effectiveness and safety of tolperisone in spasticity following cerebral stroke: randomized, double-blind, placebo-controlled trial]. Ideggyogy Sz. 2013 Jul 30;66(7-8):283-4. Hungarian. PubMed PMID: 23971362.
12: Quasthoff S, Möckel C, Zieglgänsberger W, Schreibmayer W. Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects. CNS Neurosci Ther. 2008 Summer;14(2):107-19. doi: 10.1111/j.1527-3458.2008.00044.x. Review. PubMed PMID: 18482024.
13: Glück J, Rymarczyk B, Rogala B. An immediate hypersensitivity reaction caused by tolperisone hydrochloride. J Investig Allergol Clin Immunol. 2011;21(5):411-2. PubMed PMID: 21905508.
14: Bae JW, Kim MJ, Park YS, Myung CS, Jang CG, Lee SY. Considerable interindividual variation in the pharmacokinetics of tolperisone HCl. Int J Clin Pharmacol Ther. 2007 Feb;45(2):110-3. PubMed PMID: 17323790.
15: Zakharov IaIu, Shirokov VA, Dudin DL. [The effect of tolperisone on the functional state of peripheral motoneurons]. Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(3):65-8. Russian. PubMed PMID: 23612413.
16: Orgován G, Tihanyi K, Noszál B. NMR analysis, protonation equilibria and decomposition kinetics of tolperisone. J Pharm Biomed Anal. 2009 Dec 5;50(5):718-23. doi: 10.1016/j.jpba.2009.05.036. Epub 2009 Jun 6. PubMed PMID: 19577875.
17: Bae JW, Park YS, Sohn UD, Myung CS, Ryu BK, Jang CG, Lee SY. HPLC determination of tolperisone in human plasma. Arch Pharm Res. 2006 Apr;29(4):339-42. PubMed PMID: 16681042.
18: Stamenova P, Koytchev R, Kuhn K, Hanasen C, Horvath F, Ramm S, Pongratz D. [A randomized, double blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(1):34-42. Russian. PubMed PMID: 16457132.
19: Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S, Gere A, Csejtei M, Tarnawa I. Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels. J Pharmacol Exp Ther. 2005 Dec;315(3):1237-46. Epub 2005 Aug 26. PubMed PMID: 16126840.
20: Vora A. Tolperisone. J Assoc Physicians India. 2010 Feb;58:127-8. PubMed PMID: 20653161.